Petros Pharmaceuticals Prices $9.6 Million Public Offering of Common Stock and Warrants

Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals entered securities purchase agreement for 13,950,012 units and 26,049,988 pre-funded units at $0.24 and $0.2399 per unit.
Offering closed on February 19, 2025, with gross proceeds of approximately $9.6 million.
Each unit includes one share (or pre-funded warrant), one Series A warrant (0.25 share) and one Series B warrant (1 share) at $0.48 exercise price.
Warrants exercisable only upon stockholder approval; pre-funded warrants immediately exercisable at $0.0001 per share.
Company granted 1,000,000, 300,000, 150,000, 450,000, 150,000, and 150,000 restricted shares to directors Silverman, Bernstein, Walker, Boctor, Arnold, and Weinstein.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.